thisdrug what a medicine's name tells you

WHO naming stem · suffix · 32 listed names

-kin

This page was written with AI.

interleukin type substances

WHO's definition, quoted as written in the 2024 stem book

2 of 32 names appear in these lists: 2 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 1 has national brands in at least one EU/EEA country.

Names only. This page is about -kin as a part of a name. It has nothing on uses, doses, side effects or interactions of any medicine that carries it, and nothing here is medical advice. Ask a pharmacist or doctor about the medicine itself.

Where it sits in a name

WHO writes the stem as -kin. So the letters kin sit at the end of the name (…kin).

All 32 names WHO lists under -kin

These are the INN in group (a) of Part IV of the stem book: names in which WHO says the stem is used as defined. The stem is marked where WHO places it. A-Z as WHO lists them.

Beside each name: the brand names it appears under in the US list (FDA Drugs@FDA) and the EU central list (EMA), or that neither list carries it. 2 of 32 names appear in these lists: 2 in the US list (FDA Drugs@FDA) and 0 in the EU central list (EMA); 1 has national brands in at least one EU/EEA country. Each brand opens in this site's brand lookup. A name is found when the agency's ingredient name is the same name once salt words such as hydrochloride or sodium are set aside (the list of those words); where WHO's own name carries such a word (estradiol valerate), the agency must write the same words. A spelling that differs only by the INN letter rules (ph for f, y for i) is found too and shown. Under each name that one or more EU/EEA countries authorise under a national brand of their own (through that country's agency, so not in the EU central list), a line now gives the number of those countries and their codes, from EMA's Article 57 data, and opens the country lookup at that name. A name with none of these lines may still be sold elsewhere, or in Europe only under its own generic name.

  1. adargileukin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  2. aldesleukin
    US brands: PROLEUKIN
    EU (central) brands: none found
  3. atexakin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  4. avipendekin pegol
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  5. bempegaldesleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  6. binetrakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  7. canoctakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  8. celmoleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  9. cergutuzumab amunaleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  10. cintredekin besudotox
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  11. denenicokin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  12. denileukin diftitox
    US brands: LYMPHIR, ONTAK
    EU (central) brands: none found
  13. edodekin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  14. efavaleukin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  15. efineptakin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  16. eflepedocokin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  17. emoctakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  18. fbalropendekin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  19. iboctadekin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  20. ilodecakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  21. melredableukin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  22. mobenakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  23. nogapendekin alfa
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  24. oprelvekin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  25. pegaldesleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  26. pegenzileukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  27. pegilodecakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  28. pifonakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  29. pimroctakin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  30. rezpegaldesleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  31. teceleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)
  32. tucotuzumab celmoleukin
    Not found in the US or EU-central lists (checked 2026-09-23 and 2026-09-24)

US list: Drugs@FDA, from the FDA Drugs@FDA data (openFDA bulk file), checked . It keeps discontinued brands, marked here as FDA marks them.

EU (central) list: EMA medicines list, European Medicines Agency (EMA), checked . Medicines authorised for the whole EU through EMA only: a brand authorised by one country's own agency is not in it. Source: European Medicines Agency (EMA), medicines list, checked 2026-09-24.

EU/EEA national lists: European Medicines Agency (EMA), Article 57 product data, downloaded (EMA's Article 57 page). Brand names authorised by each country's own agency, as the country lookup reads them; a product named after its substance and maker ("Paracetamol Teva") is not counted as a brand, and EU central authorisations are not counted as a country. GB in a list is Northern Ireland, which EMA's data carries alongside the EU/EEA countries.

Same group, without the stem

WHO also lists these 2 names under -kin: group (c) of Part IV of the 2024 stem book, “INN which belong to the same group of pharmaceutical substances but in which the stem is not used”. They belong to the same group of substances as the group (a) names above, yet they do not carry -kin, so the name alone does not reveal the group.

  1. daniplestim
  2. muplestim

Decode another name

Decoded

emoctakin

Listed INNCarries 2 WHO stems, most specific first: octakin …

  • octakinend of the nameWHO lists it hereWHO definition: interleukin-8 analogues and derivatives
  • -kinend of the nameWHO lists it hereWHO definition: interleukin type substances

“emoctakin” is an INN that WHO lists under octakin, -kin in the 2024 stem book.

The same decoder as the front page: it reads the letters of a name against all 482 WHO stems, in your browser.

Source and licence

The definition of -kin (Part II B) and the 32 names (Part IV, group (a)), and the 2 of the same group without the stem (group (c)) are from Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024 (World Health Organization, Stem book 2024 (ISBN 978-92-4-009938-8); covers proposed INN Lists 1-129). Checked .

Adapted from: Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances, 2024. Geneva: World Health Organization; 2024. Licence: CC BY-NC-SA 3.0 IGO. This adaptation was not created by WHO; WHO is not responsible for its content or accuracy and does not endorse this site. The data file stems.json is shared under the same licence.

Made with AI tools. · Privacy